I tried microdosing Mounjaro for a very common, debilitating condition – what happened next was life-changing
A growing number of GLP-1 users are ‘microdosing’ – they say small amounts of the drug have helped reduce symptoms of various health conditions, without any of the negative side effects.
Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030
Key Points Eli Lilly has plenty of medium-term catalysts that should power a strong performance through 2030. Berkshire Hathaway, by contrast, is facing some headwinds that may limit its upside. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) and Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) don’t have a lot in […]
What's Behind the Drop in US Obesity
While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don’t think they are having a major impact.
Odd Lots: The Viral Milk Fueling the US Protein Boom (Podcast)
Protein seems to be everywhere these days, with brands from Starbucks to Pepsi jumping on the trend. But the obsession with protein may have started earlier — with a humble dairy product that defied the broader decline in US milk consumption. Fairlife, which uses a specialized filtering process to boost protein and cut sugar and […]
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here’s What This Means for Investors.
Key Points Eli Lilly struck a deal with President Donald Trump, lowering the prices of its blockbuster weight loss drugs. In return, Lilly gains exemption from import tariffs and other benefits. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) has seen revenue soar in recent quarters thanks to one portfolio […]
Jim Cramer on Amgen: “They Have A Lot of Good Medicines”
Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer recently shared thoughts on. Cramer said that the company needs to “broaden the portfolio,” as he remarked: “Look, I think Amgen needs to do something because they’ve gotta broaden the portfolio where they need to be able to tell a little bit better story about […]
Jim Cramer Says “Look, in the End, There’s Eli Lilly and There’s Everybody Else”
Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently shared thoughts on. Cramer mentioned the stock during the episode and commented: “I do believe that there are very few biotechs that I really want to buy right now because they’re so picked over. Look, in the end, there’s Eli Lilly and […]
12 Reasons Why Trump May Be Losing The Plot
Photo Illustration by Thomas Levinson/The Daily Beast/Getty He spoke about people being forced to flee “South Africa” due to communism, when he meant to say “South America.” He recalled getting “indicted” over allegations he improperly sought help from Ukraine, when in reality he was “impeached.” And he was caught on camera appearing to nod off […]
Why Isn’t There a Cure for Alzheimer’s Disease?
Medicine is strongly biased towards adopting biochemical models of disease as this facilitates costly therapeutics being developed for each disease and hence sustains the medical industry. Unfortunately, in many cases, the biochemical approach to disease, at best can manage symptoms, and as a result, many conditions remain “incurable” while non-patentable natural therapies that can cure […]
The Surprising New Side Effect Of Taking GLP-1 Medications
Post Content